Sugi Predict

Sugi Predict / Compounds / Edotreotide

Edotreotide

Edotreotide

SCHEMBL29533812

C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)CN2CCN(CC(=O)[O-])CCN(CC(=O)[O-])CCN(CC(=O)[O-])CC2)CSSC[C@@H](C(=O)N[C@H](CO)[C@@H](C)O)NC1=O.[177Lu+3]

nearest known ligand 0.92

Full drug profile on Sugi Atlas →

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ SSTR2 P30874 16/20 0.92
▸ SSTR5 P35346 7/20 0.92
▸ SSTR3 P32745 4/20 0.92
▸ SSTR4 P31391 10/20 0.88
▸ SSTR1 P30872 2/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Edotreotide SCHEMBL29376309 0.99 SSTR2 (0.92) SSTR2SSTR5SSTR3SSTR4SSTR1
Edotreotide SCHEMBL29760280 0.99 SSTR2 (0.92) SSTR2SSTR5SSTR3SSTR4SSTR1
Edotreotide SCHEMBL25448984 0.96 SSTR2 (1.00) SSTR2SSTR5SSTR3SSTR4SSTR1
Edotreotide SCHEMBL24087491 0.96 SSTR2 (1.00) SSTR2SSTR5SSTR3SSTR4SSTR1
Edotreotide SCHEMBL21652492 0.96 SSTR2 (1.00) SSTR2SSTR5SSTR3SSTR4SSTR1
Edotreotide SCHEMBL25448975 0.96 SSTR2 (1.00) SSTR2SSTR5SSTR3SSTR4SSTR1
Edotreotide SCHEMBL1649285 0.96 SSTR2 (1.00) SSTR2SSTR5SSTR3SSTR4SSTR1
Edotreotide SCHEMBL19712197 0.96 SSTR2 (1.00) SSTR2SSTR5SSTR3SSTR4SSTR1
SCHEMBL24828846 0.95 SSTR2 (0.94) SSTR2SSTR5SSTR3SSTR4SSTR1
SCHEMBL30151657 0.95 SSTR2 (0.94) SSTR2SSTR5SSTR3SSTR4SSTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250295587-A1 COMPLEX LIPID NANOPARTICLES ENCAPSULATING POLYPEPTIDES AND USES THEREOF SAIL BIOMEDICINES, INC. 2025-09-25 — — US disclosed
US-20240408387-A1 COMBINATION ELECTRICAL THERAPY WITH OTHER CANCER THERAPIES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2024-12-12 — — US disclosed
US-20240398884-A1 PLANT MESSENGER PACKS ENCAPSULATING POLYPEPTIDES AND USES THEREOF FLAGSHIP PIONEERING INNOVATIONS VI LLC (US) 2024-12-05 — — US disclosed
US-20220288150-A1 PLANT MESSENGER PACKS ENCAPSULATING POLYPEPTIDES AND USES THEREOF FLAGSHIP PIONEERING INNOVATIONS VI, LLC 2022-09-15 — — US disclosed
US-20220152139-A1 PLANT MESSENGER PACKS ENCAPSULATING POLYPEPTIDES AND USES THEREOF FLAGSHIP PIONEERING INNOVATIONS VI, LLC 2022-05-19 — — US disclosed